- Home
- ORMP vs L Comparison
ORMP vs L Comparison
Compare ORMP & L Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | L |
|---|---|---|
| Founded | 2002 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 21.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | L |
|---|---|---|
| Price | $2.92 | $106.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 226.0K | ★ 942.0K |
| Earning Date | 11-13-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 838.25 | N/A |
| EPS | 1.03 | ★ 6.86 |
| Revenue | $2,000,000.00 | ★ $18,266,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $2.90 | $15.44 |
| Revenue Growth | N/A | ★ 6.06 |
| 52 Week Low | $1.82 | $78.98 |
| 52 Week High | $3.20 | $109.06 |
Technical Indicators
Market Signals| Indicator | ORMP | L |
|---|---|---|
| Relative Strength Index (RSI) | 55.93 | 58.58 |
| Support Level | $2.66 | $103.53 |
| Resistance Level | $3.19 | $109.06 |
| Average True Range (ATR) | 0.14 | 1.59 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 37.04 | 90.71 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.